Consolidated Statements of Stockholders' Equity - USD ($) |
Preferred Stock Subscription [Member]
Series D Preferred Stock [Member]
|
Preferred Stock Subscription [Member] |
Preferred Stock Subscriptions Receivable [Member]
Series D Preferred Stock [Member]
|
Preferred Stock Subscriptions Receivable [Member] |
Common Stock [Member]
Series D Preferred Stock [Member]
|
Common Stock [Member] |
Common Stock Subscription [Member]
Series D Preferred Stock [Member]
|
Common Stock Subscription [Member] |
Common Stock Subscriptions Receivable [Member] |
Additional Paid-in Capital [Member]
Series D Preferred Stock [Member]
|
Additional Paid-in Capital [Member]
Series E Preferred Stock [Member]
|
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Noncontrolling Interest [Member] |
Preferred Stock [Member]
Series D Preferred Stock [Member]
|
Preferred Stock [Member]
Series E Preferred Stock [Member]
|
Preferred Stock [Member] |
Series D Preferred Stock [Member] |
Series E Preferred Stock [Member] |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balance (in shares) at Dec. 31, 2020 | 132,250 | 27,149,691 | 995,000 | |||||||||||||||||
Balance at Dec. 31, 2020 | $ 132 | $ (10,300,000) | $ 218,146 | $ 995 | $ (4,975,000) | $ 375,428,014 | $ (359,056,683) | $ 731,303 | $ 2,046,907 | |||||||||||
Issued restricted stock (in shares) | 12,500 | |||||||||||||||||||
Issued restricted stock | $ 13 | $ 13 | ||||||||||||||||||
Issued stock to 401(k) plan (in shares) | 30,018 | 30,018 | ||||||||||||||||||
Issued stock to 401(k) plan | $ 30 | 76,816 | $ 76,846 | |||||||||||||||||
Issued stock (in shares) | (31,750) | 31,750 | 50,000 | |||||||||||||||||
Issued stock | $ (31) | $ 250,000 | $ 4,980,659 | $ 32 | $ 50 | $ 250,001 | $ 4,980,709 | |||||||||||||
Issued stock upon conversion (in shares) | 1,513,978 | 0 | (31,750) | |||||||||||||||||
Issued stock upon conversion | $ 1,514 | $ (1,482) | $ (32) | |||||||||||||||||
Stock subscribed (in shares) | 0 | |||||||||||||||||||
Stock subscribed | $ 0 | $ 500,000 | $ 0 | $ 500,000 | ||||||||||||||||
Stock compensation expense | 121,298 | 121,298 | ||||||||||||||||||
Net loss | (2,966,890) | (2) | (2,966,892) | |||||||||||||||||
Balance (in shares) at Mar. 31, 2021 | 100,500 | 28,706,187 | 995,000 | 50,000 | ||||||||||||||||
Balance at Mar. 31, 2021 | $ 101 | $ (9,550,000) | $ 219,703 | $ 995 | $ (4,975,000) | 380,605,305 | (362,023,573) | 731,301 | 5,008,882 | |||||||||||
Balance (in shares) at Dec. 31, 2021 | 30,279,922 | |||||||||||||||||||
Balance at Dec. 31, 2021 | $ 221,277 | 370,459,705 | (370,787,610) | 731,299 | $ 624,743 | |||||||||||||||
Issued stock to 401(k) plan (in shares) | 53,238 | 0 | 53,238 | |||||||||||||||||
Issued stock to 401(k) plan | 0 | 0 | $ 44,720 | |||||||||||||||||
Stock compensation expense | $ 0 | 184,850 | 0 | 0 | $ 0 | 184,850 | ||||||||||||||
Net loss | $ 0 | 0 | (2,987,242) | (3) | $ 0 | (2,987,245) | ||||||||||||||
Balance (in shares) at Mar. 31, 2022 | 30,357,292 | 72,077 | ||||||||||||||||||
Balance at Mar. 31, 2022 | $ 221,354 | $ 371,151,466 | $ (373,774,852) | $ 292,518 | $ (2,109,442) |
X | ||||||||||
- Definition Number of shares subscribed during period. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of stock subscribed during period. No definition available.
|
X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of shares issued during the period as a result of the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares related to Restricted Stock Award forfeited during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The gross value of stock issued during the period upon the conversion of convertible securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan. No definition available.
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Aggregate value of stock related to Restricted Stock Awards issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|